Parkinson's Disease
Course
In
Description
-
Type
Course
-
Duration
2 Days
This two-day course will provide delegates with an understanding of Parkinson's Disease and the rapidly evolving developments in the understanding and treatment of this disease. Suitable for: Pharmaceutical industry personnel from clinical research, medical affairs and regulatory functions as well as individuals in strategic marketing and business functions.
Reviews
Teachers and trainers (1)
Dr. Donald Grosset
Chairman
Southern General Hospital Glasgow
Course programme
Course Description
Key concepts concerning the aetiology and the underlying pathology of Parkinson's Disease will be explained and the spectrum of clinical presentations reviewed. Investigative methods, focusing on imaging, will be addressed along with the differential diagnosis. The values and limitations of these techniques in both clinical practice and research will be evaluated.
Current pharmacological management as well as surgical options will be discussed with specific attention placed on future directions and important innovations in the field.
The challenges of clinical trial design for Parkinson's Disease therapies will be explored with a focus on patient selection, evaluative methods and key rating scales used in clinical research.
Additionally, delegates will benefit from hearing the experiences of a patient living with Parkinson's Disease. Discussion time and group work will provide opportunities throughout the course for questions and debate.
CPD accreditation:
Healthcare's programmes are approved by the Faculty of Pharmaceutical Medicine for CPD accreditation. Details can be supplied on request.
Topics to be covered include:
- Introduction to Parkinson's Disease
- Aetiology
- Epidemiology and pathology
- Imaging
- Current pharmacological management
- Non-pharmacological management
- Neurosurgical treatment
- Issues in clinical trial design
- Future therapies
Additional information
Parkinson's Disease